How much is FlightPath (Drug Discovery) worth in 2026?

FlightPath (Drug Discovery) has a current valuation of $21.0M based on their Later Stage VC round and secondary market data.

How much funding has FlightPath (Drug Discovery) raised?

FlightPath (Drug Discovery) has raised $9.7M in total funding across 0 funding rounds.

FlightPath (Drug Discovery)

Website

FlightPath (Drug Discovery) valuation and funding history | Last updated: October 23, 2024

Current Valuation

$21.0M

As of October 23, 2024

Total Funding Raised

$9.7M

Last Round

Later Stage VC

$8.1M

Last Funding

Oct 2024

Funding date

Capital Efficiency

2.17x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

FlightPath (Drug Discovery) is currently valued at $21.0M as of October 23, 2024. The company has raised a total of $9.7M in funding.

Capital Efficiency

With a capital efficiency ratio of 2.17x, FlightPath (Drug Discovery) has achieved a valuation that is 2.17 times the total capital raised.

Track FlightPath (Drug Discovery) Valuation Updates

Get notified when FlightPath (Drug Discovery) raises new funding or valuation changes

Explore More Data

Detailed analysis for FlightPath (Drug Discovery)

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock FlightPath (Drug Discovery)'s valuation history, funding rounds, and growth metrics.

No credit card required

What is FlightPath (Drug Discovery) Worth in 2026?

FlightPath (Drug Discovery) is a leading private company in the technology sector. Track FlightPath (Drug Discovery)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How FlightPath (Drug Discovery) Valuation is Determined

Private company valuations like FlightPath (Drug Discovery)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.